Efavirenz and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Efavirenz (efavirenz) and Ifosfamide (ifosfamide). Common drug interactions include acquired immunodeficiency syndrome among females and burkitt's lymphoma among males.

The phase IV clinical study analyzes what interactions people have when they take Efavirenz and Ifosfamide. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Efavirenz?

Efavirenz has active ingredients of efavirenz. It is often used in hiv infection. eHealthMe is studying from 15,501 Efavirenz users. Check the latest studies of Efavirenz.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

On Aug, 01, 2026

20 people who take Efavirenz and Ifosfamide together, and have interactions are studied.

Efavirenz and Ifosfamide drug interactions.

What are the common drug interactions of Efavirenz and Ifosfamide, by gender? *:

female:

Acquired immunodeficiency syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv))
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cerebral haemorrhage (bleeding within the brain)
Chest pain
Coma (state of unconsciousness lasting more than six hours)
Eructation (release of gas from the digestive tract)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic failure (liver failure)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

male:

Burkitt's lymphoma (cancer of the lymphatic system)
Drug ineffective
Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
Blood glucose increased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Impaired fasting glucose
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Efavirenz and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood glucose increased
Drug ineffective
Impaired fasting glucose

50-59:

Burkitt's lymphoma (cancer of the lymphatic system)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Eructation (release of gas from the digestive tract)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic failure (liver failure)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Lymphoma (cancer that begins in immune system cells)
Malignant neoplasm progression (cancer tumour came back)
Platelet count decreased

60+:

n/a

What are the existing conditions these people have? *

Burkitt's Lymphoma (cancer of the lymphatic system): 15 people, 75.00%
Hodgkin's Lymphoma (cancer originating from white blood cells): 4 people, 20.00%
Lymphoma (cancer that begins in immune system cells): 1 person, 5.00%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Efavirenz and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously